Skip to main content
. 2021 Jun 30;10(13):e020917. doi: 10.1161/JAHA.121.020917

Figure 4. Receiver operating characteristic curves showing the levels of MRproANP measured before the procedure in PV blood, the LA blood, and RA blood predicting the recurrence of atrial fibrillation up to 1 year after catheter ablation.

Figure 4

LA indicates left atrium; MRproANP, midregional N‐terminal pro–atrial natriuretic peptide; PV, peripheral venous; and RA, right atrium.